IRVINE, Calif., May 6, 2021 / PRNewswire / – BIOLASE, Inc. (NASDAQ: BIOL), the world leader in dental lasers, today announced its Waterlase Pediatric Dental Academy (WPDA) for Waterlase pediatric dentists. The WPDA will provide clinicians with an immersive training experience through peer-led learning, best practice sharing and ongoing mentorship to ensure optimal integration of Waterlase technology into clinical practices.
“Pediatric dentists are actively seeking new ways to treat their young patients in a gentler and more holistic way than traditional dental equipment offers, and we saw this as an opportunity to live up to our mission to advance dentistry in this community. said John Beaver, President and CEO of BIOLASE. “From minimally invasive infant and toddler tongue tie delivery to no-injection cavity preparations, Waterlase is the perfect addition to any pediatric practice to help children feel more comfortable in the chair and hopefully instill lifelong healthy oral care practices.”
As part of the WPDA, members have access to both virtual and in-person continuing education opportunities, as well as clinical support sessions to discuss cases, best practice techniques, and exclusive web content. The Academy leadership includes several experienced pediatric dentists, including Dr. Ben Curtis, who serves as the Executive Director, Drs. Cherish Leung, Linda Murzyn-Dantzer, and Reena Kuba.
“I believe dental lasers are the future of dentistry, and I am thrilled to be part of an academy that gives pediatric dentists the opportunity to collaborate, learn and train with Waterlase,” said Dr. Ben Curtis. “My practice has benefited immensely from the diverse therapies that the Waterlase laser offers, from limiting the time patients sit in the chair to allowing minimally invasive treatments that will take the anxiety out of their visit. those in the pediatric dental community. to experience the same results. “
All-tissue waterlase dental lasers provide pediatric physicians with the ability to gently and accurately remove tooth decay, with fewer aerosols, less vibration, and little to no anesthesia. It can also perform soft tissue procedures with less blood and faster healing than traditional scalpel and suture methods. The versatility of Waterlase combined with the ongoing education, training and clinical fellowship of the WPDA allows every pediatric physician to integrate the technology and offer laser dentistry to their patients. The formation of the WPDA follows on the heels of the recently established specialist academies, the Waterlase Perio Academy and Waterlase Endo Academy.
Learn more about the Waterlase Pediatric Dental Academy at biolase.com/wpda.
About BIOLASE, Inc.
BIOLASE is a medical device company that develops, manufactures, markets and sells laser systems for dentistry and medicine. BIOLASE products promote the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE’s proprietary laser products contain approximately 271 patented and 40 patented technologies designed to deliver superior biologically and clinically performance with less pain and faster recovery times. BIOLASE’s innovative products offer advanced technology at competitive prices to deliver superior results for dentists and patients. BIOLASE’s flagship products are revolutionary dental laser systems that perform a wide variety of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold more than 41,200 laser systems in more than 80 countries around the world to date. Laser products in development target the BIOLASE core dental market and other adjacent medical and consumer applications.
For updates and information on Waterlase iPlus®, Waterlase Express ™ and laser dentistry, visit BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www .instagram .com / waterlase_laserdentistry and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
SOURCE BIOLASE, Inc.